Getting more high-quality sleep gives you energy to exercise and eat well throughout the day
La tirzepatida (15 mg una vez a la semana), un agonista dual que acta sobre los receptores GLP-1 y GIP, produjo una prdida de peso de hasta el 17,8% despus de 72 semanas , y la semaglutida (2,4 mg una vez a la semana) produjo una prdida de peso de hasta el 13,9% despus de 68 semanas, ambas en comparacin con placebo
Statements Author contributions GM: Writing review & editing, Writing original draft
He noted that the number would be even higher if it were an exclusively female sample and said it's "a signal worth investigating." The study found that approximately 44 percent of users reported at least one side effect, most commonly gastrointestinal issues, including 37 percent reporting nausea, which "shows that the method is picking up a real signal," according to Sharath Chandra Guntuku, the study's senior author